Radiofrequency For Chronic Knee Pain Post-Arthroplasty
CompletedNot applicableNCT02931435
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic knee osteoarthritis (OA) is one of the most common diseases with increasing prevalence in advanced age. Knee OA results in movement restriction, sleep disturbance, and disability. Total knee arthroplasty (TKA) is employed often in the symptomatic treatment of knee OA. It has been estimated that 3.4 million TKAs will be performed in the year 2030 in the United States alone. Many studies report rewarding outcomes for patients, but other research shows there are many patients that remain dissatisfied post-arthroplasty. The purpose of this study is to evaluate whether genicular radiofrequency ablation can relieve chronic post-arthroplasty knee pain.
Study details
- Official title
- Radiofrequency For The Treatment Of Chronic Knee Pain Following Total Knee Arthroplasty: A Double-Blind Randomized Controlled Pilot Study
- Conditions
- Interventions
- Procedure: Nerve Block with Radiofrequency Ablation
- Procedure: Nerve Block with Sham Radiofrequency Ablation
- Sponsor
- Randall Brewer, MD, CPI
- Collaborators
- Abbott Medical Devices; Abbott
- Organization
- Willis-Knighton River Cities Clinical Research Center
- Start date
- 2016-12
- Primary completion
- 2018-11-20
- Sex
- All
- Age range
- from 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Study candidate must provide written informed consent. * Must be ≥ 50 years of age at the time of consent * Chronic knee pain despite total knee arthroplasty at least 6 months prior to consent * Orthopedic evaluation indicating no further surgery is warranted * Stable pain medication regimen for 30 days prior to baseline visit * Knee pain is primary pain complaint Exclusion Criteria: * Acute knee pain * Connective tissue disorders affecting the knee * Serious neurologic or psychiatric disorders that would affect the outcome of the study as determined by the Principal Investigator * Steroid or hyaluronic acid injections into the affected knee in the past 3 months * Confounding pain conditions of the index leg that may affect medication requirements or study outcomes
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02931435